Standard Operating Procedure for Prospective Individualised Dosimetry for ([131])I-rituximab Radioimmunotherapy of Non-Hodgkin's Lymphoma

Radioimmunotherapy (RIT) is an attractive therapy for non-Hodgkin's lymphoma (NHL) as it allows targeted tumor irradiation which provides a cytotoxic effect significantly greater than that of the immune-mediated effects of a non-radioactive, or ‘cold’, antibody alone. Anti-CD20 antibodies such...

Descripción completa

Detalles Bibliográficos
Autores principales: Calais, Phillipe J., Turner, J. Harvey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555354/
https://www.ncbi.nlm.nih.gov/pubmed/23372448
http://dx.doi.org/10.4103/1450-1147.103409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555354/
https://www.ncbi.nlm.nih.gov/pubmed/23372448
http://dx.doi.org/10.4103/1450-1147.103409

Ejemplares similares